Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 309 KB, PDF document
Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage
Original language | English |
---|---|
Journal | Cancer communications (London, England) |
Number of pages | 5 |
ISSN | 2523-3548 |
DOIs | |
Publication status | E-pub ahead of print - 2024 |
ID: 386143192